JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 243 filers reported holding JUNO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $667,000 | +2.5% | 14,587 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $651,000 | -94.9% | 14,510 | -96.6% | 0.00% | -95.7% |
Q2 2017 | $12,822,000 | +352.1% | 428,968 | +235.6% | 0.02% | +360.0% |
Q1 2017 | $2,836,000 | +425.2% | 127,827 | +610.2% | 0.01% | +400.0% |
Q3 2016 | $540,000 | -94.5% | 18,000 | -93.1% | 0.00% | -96.0% |
Q1 2016 | $9,897,000 | +3512.0% | 259,822 | +4066.5% | 0.02% | +2400.0% |
Q4 2015 | $274,000 | +18.1% | 6,236 | +9.4% | 0.00% | – |
Q3 2015 | $232,000 | -82.6% | 5,700 | -77.2% | 0.00% | -100.0% |
Q2 2015 | $1,334,000 | -76.9% | 25,010 | -77.3% | 0.00% | -75.0% |
Q4 2014 | $5,766,000 | – | 110,410 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|